Please ensure Javascript is enabled for purposes of website accessibility

Bonds: Out. Stocks: Out. What's Left?

By Alex Dumortier, CFA – Updated Apr 6, 2017 at 12:15AM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Resolving this conundrum can protect your wealth.

In his most recent report, respected asset allocation consultant Andrew Smithers concludes that basically all bonds are overpriced (see table below), whether they be guvvies (government bonds), corporates, or inflation-protected. That's pretty unfortunate, especially when you consider that stocks are also broadly overvalued. So what's left for an investor?

Investment

Yield

10-year Treasury bond

3.27%

10-year Treasury Inflation-Protected Securities (TIPS)

1.08% [real]

Investment-grade corporate bonds*

4.92%

High yield corporate bonds*

9.79%

Treasury bond data as of Dec. 1, 2009. Corporate bond date as of Nov. 30, 2009.
*Average redemption yield.
Source: Bloomberg

Cash is the worst asset -- except for all the others ...
Both stocks and bonds currently promise poor returns because investors are bidding prices up, desperate to put their cash to work anywhere there's a hope of earning something greater than zero. But whether these assets will end up working for or against them remains to be seen. Cash has some interesting attributes: It presents no risk of capital loss, and it leaves investors with flexibility.

Investors don't need to choose between buying risky assets immediately or holding cash for the next 10 years. When the former are overvalued, one can simply hold cash until prices become more attractive. In my opinion, we certainly won't have to wait 10 years for that to happen.

Stockpicking is an alternative
One alternative, for investors with the necessary time and the expertise, is buying carefully selected, well-priced stocks (yes, there are still some out there). The following shares, for example, are in the top 10% of the S&P 500 in terms of their forward earnings yield. (They are not recommendations -- please do your own due diligence.)

Company

Forward Earnings Yield

Long-Term Earnings Growth Estimate

ConocoPhillips (NYSE:COP)

11.2%

7%

UnitedHealth Group (NYSE:UNH)

10.6%

12.5%

Eli Lilly (NYSE:LLY)

12%

5.3%

Pfizer (NYSE:PFE)

12.3%

(0.3%)

Loews (NYSE:L)

11%

-

Constellation Brands (NYSE:STZ)

9.7%

9%

AFLAC (NYSE:AFL)

11.2%

14.3%

Source: Capital IQ, a division of Standard & Poor's and author's calculations, based on data from same.

The game plan
Unless you're investing in individually selected stocks, rather than through index funds, I recommend being underweight the broad U.S. stock market and bonds. Holding cash doesn't make sense unless none of the alternatives do. By and large, that's  the case right now. When -- not "if" -- asset prices become more consistent with economic reality, that cash will come in mighty handy.

Be wary of pundits who are goading investors into chasing returns. Here are three more reasons you're being set up to fail.

Sustainable dividend growth is the hallmark of a high-quality business. The team at Motley Fool Income Investor can show you how to build – and manage – a portfolio of high quality company stocks that produce a robust dividend yield. To find out their six 'Buy First' stocks, take advantage of a 30-day free trial today.

Fool contributor Alex Dumortier, CFA has no beneficial interest in any of the companies mentioned in this article. AFLAC and UnitedHealth Group are Motley Fool Stock Advisor recommendations. Pfizer and UnitedHealth are Motley Fool Inside Value picks. The Fool owns shares of UnitedHealth. Try any of our Foolish newsletter services free for 30 days. The Fool has a disclosure policy.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Eli Lilly and Company Stock Quote
Eli Lilly and Company
LLY
$308.10 (-1.08%) $-3.36
ConocoPhillips Stock Quote
ConocoPhillips
COP
$99.86 (-0.72%) $0.73
Pfizer Inc. Stock Quote
Pfizer Inc.
PFE
$43.82 (-0.59%) $0.26
UnitedHealth Group Incorporated Stock Quote
UnitedHealth Group Incorporated
UNH
$509.83 (-0.74%) $-3.78
Loews Corporation Stock Quote
Loews Corporation
L
$49.80 (-2.35%) $-1.20
Aflac Incorporated Stock Quote
Aflac Incorporated
AFL
$57.00 (-1.37%) $0.79
Constellation Brands, Inc. Stock Quote
Constellation Brands, Inc.
STZ
$232.82 (0.68%) $1.56

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
329%
 
S&P 500 Returns
106%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 09/26/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.